• New resources
  • Information for young doctors
  • Information for health professionals conference 2011
  • Information for health professionals conference 2011
  • ASCIA Conference 2015
  • Information for health professionals conference 2013

Action Plans for Anaphylaxis and Allergic Reactions - FAQ

The following ASCIA Action Plans (personal) include text fields to type in patient details:

anaphylaxis action plan epipen personal red ss

ASCIA Action Plan for Anaphylaxis (personal) for use with EpiPen

pdfASCIA Action Plan for Anaphylaxis (personal) for use with EpiPen283.12 KB

anaphylaxis action plan anapen personal red ss

ASCIA Action Plan for Anaphylaxis (personal) for use with Anapen  

pdfASCIA Action Plan for Anaphylaxis (personal) for use with Anapen235.21 KB

ASCIA Action Plan for Allergic Reactions (personal)

ASCIA Action Plan for Allergic Reactions (personal) for use when
no adrenaline autoinjector has been prescribed  

pdfASCIA Action Plan for Allergic Reactions (personal)211.49 KB

 The following ASCIA Action Plans (general) can be used as posters or in first aid kits:

Action Plan for Anaphylaxis (general) for use with EpiPen

Action Plan for Anaphylaxis (general) for use with EpiPen 

pdfAction Plan for Anaphylaxis (general) for use with EpiPen229.61 KB 

Action Plan for Anaphylaxis (general) for use with EpiPen

ASCIA Action Plan for Anaphylaxis (general) for use with Anapen

pdfASCIA Action Plan for Anaphylaxis (general) for use with Anapen 360.46 KB

Important information:

1. ASCIA Action Plans for Anaphylaxis can be used for individuals with food and insect allergies (ASCIA Action Plans specific for Insect Allergy were discontinued in March 2011).

2. ASCIA Action Plans for Anaphylaxis include instructions on how to use an adrenaline autoinjector and should always be stored with the device.

3. Adrenaline autoinjectors contain a fixed dose of adrenaline and are designed to be used by anyone (medical training is not required), including friends, teacher, childcare worker, parents or patients (if they are old and well enough).

The following are the most frequently asked questions and answers (FAQ) regarding the ASCIA Action Plans for Anaphylaxis and Allergic Reactions.

Frequently Asked Questions (FAQ) and Answers 

pdfASCIA PCC Action Plan FAQs 2014211.99 KB

Q 1: How many types of ASCIA Action Plans are there?

There are two types of ASCIA Action Plans for Anaphylaxis (General and Personal) and two versions for each of these, specific to the adrenaline autoinjector brand (EpiPen or Anapen).  The General versions (orange) do not contain any personal information and can be used as a poster.  The Personal versions (red) include personal information for the individual with prescribed adrenaline autoinjector/s, such as medically confirmed severe allergies. 

There is also an ASCIA Action Plan for Allergic Reactions (green) which includes personal information of the individual with medically confirmed mild or moderate allergies, who needs to avoid certain allergens, but does not have an adrenaline autoinjector. 

ASCIA Action Plans for Anaphylaxis and Allergic Reactions have text fields that can be directly typed into.  To save ASCIA Action Plans that have patient details typed into the text fields you need to "save as" and save to document with  a new name (eg including the patient name).They can then be printed directly from the ASCIA website or the file that they have been saved to.

Alternatively hard copies can be ordered by emailing This email address is being protected from spambots. You need JavaScript enabled to view it. 

Q 2: How have the revised ASCIA Action Plans (2014) changed from the previous (2013) version?

The following amendments have been made in the 2014 versions:

  • Updated information about adrenaline autoinjectors, including revised names and a link to the instructional videos on the ASCIA website.
  • Revised information on when to commence CPR after giving adrenaline.
  • Revised information about what to do if you are unsure if it is asthma or anaphylaxis.
  • Space to include a larger patient photo on the personal (red or green) versions.

Q 3:  Can the older versions (2008, 2009) of ASCIA Action Plans still be used?

No.  These previous versions of ASCIA Action Plans should no longer be used, particularly the EpiPen versions, as the appearance of that device has changed.  ASCIA Action Plans should be renewed when patients are reassessed by their doctor, and each time they obtain a new adrenaline autoinjector prescription, which is approximately every 12 to 18 months.   If the patient is a child, the photo should be updated each time, so they can be easily identified.

Q 4:  Can schools or parents complete an ASCIA Action Plan for Anaphylaxis (personal) or ASCIA Action Plan for Allergic Reactions for their students or children? 

No.  ASCIA Action Plans have been developed as medical documents and must be completed, signed and dated by the patient's medical doctor.  If copies are required the original signed copy should be photocopied or scanned. 

Q 5:  Is it possible to obtain an electronic copy of the ASCIA Action Plans so that the child's information can be inserted by parents or school/childcare staff? 

No.  ASCIA Action Plans have been developed in a PDF format to ensure the documents are concise, consistent and easily understood.  They now have fields that can be directly typed into by the treating doctor, but not by parents, or school/childcare staff, as they are medical documents.  

Q 6:  How often does an ASCIA Action Plan need to be updated? 

ASCIA Action Plans should be reviewed when patients are reassessed by their doctor, and each time they obtain a new adrenaline autoinjector prescription, which is approximately every 12 to 18 months.   If there are no changes in diagnosis or management the medical information on the ASCIA Action Plan may not need to be updated.  However, if the patient is a child, the photo should be updated each time, so they can be easily identified.

Q 7:  The ASCIA Action Plans on the ASCIA website www.allergy.org.au are copyrighted. Can we still print them out and make copies? 

Yes.  ASCIA Action Plans can be printed off the website and/or photocopied without infringement of the copyright.  ASCIA recommends that the Action Plans are printed in colour, if possible, as they are colour coded.  

Q 8:  Who has the ASCIA Action Plan for Anaphylaxis been designed for?

ASCIA Action Plans for Anaphylaxis have been designed for first aid treatment of anaphylaxis, to be delivered by people without any special medical training nor equipment apart from access to an adrenaline autoinjector. All patients prescribed an adrenaline autoinjector should also be provided with an ASCIA Action Plan for Anaphylaxis.   

Q 9:  Why does the ASCIA Action Plan for Anaphylaxis state that CPR should only be given if the person is unresponsive and not breathing normally after giving adrenaline?

Adrenaline is life-saving and must be used promptly. Withholding or delaying the giving of adrenaline can result in deterioration and death of the patient. This is why giving the adrenaline autoinjector is a priority on the ASCIA Action Plans for Anaphylaxis, to prevent delays.  If CPR is given before this step there is a possibility that adrenaline is delayed or not given. It is important to note that oxygen will be administered to the patient by paramedics in the ambulance.    

Q 10: Who should have an ASCIA Action Plan for Allergic Reactions (green Action Plan)?

The ASCIA Action Plan for Allergic Reactions (green Action Plan) has been developed for individuals (children or adults) with a confirmed food or insect or medication allergy, who have not been prescribed an adrenaline autoinjector, as they are not thought to be at risk of anaphylaxis. However, allergies to foods, insects or medications have the potential to result in severe allergic reactions. The ASCIA Action Plan for Allergic Reactions (green Action Plan) provides guidance for carers on how to manage a severe allergic reaction should it occur. 

Q 11: Should an individual with allergic rhinitis (hay fever) have an ASCIA Action Plan for Allergic Reactions completed by their doctor?

No. Whilst allergic rhinitis can cause uncomfortable symptoms, these symptoms are not potentially life-threatening allergic reactions and hence an ASCIA Action Plan is not required. If the allergic rhinitis affects an individual's asthma, their Asthma Action Plan should be followed.

Q 12: Is there an ASCIA Treatment Plan specifically designed for individuals with allergic rhinitis (hay fever)?

Yes. The ASCIA Treatment Plan for Allergic Rhinitis has been developed for individuals with allergy to grasses, dust mite, mould etc resulting in allergic rhinitis. This Treatment Plan is completed by the individual's medical practitioner and is meant for the individual or the parent and not for schools. Most schools do not play a role in the treatment and management of allergic rhinitis. However, where medication administration is required at school, parents should liaise directly with the school.

Q 13: Can an organisation obtain an adrenaline autoinjector for general use (not prescribed for an individual) and do they require an Action Plan for Anaphylaxis?

Adrenaline autoinjectors for general use can be purchased without a prescription at full price from pharmacies. More information is available in the ASCIA document "Adrenaline autoinjectors for general use" which is available from the Anaphylaxis Resources section on the ASCIA website. The ASCIA Action Plan for Anaphylaxis (general) has been developed for use as a poster or as an instruction guide to include with an adrenaline autoinjector for general use. 

Q 14: Where can we go to obtain further resources?

Patient information and anaphylaxis training is available from ASCIA, the peak professional body for clinical immunology and allergy in Australia and New Zealand www.allergy.org.au/patients 

Patient information and support is available from the following national patient support groups for Australia and New Zealand:

 ©ASCIA 2014

The Australasian Society of Clinical Immunology and Allergy (ASCIA) is the peak professional body of Clinical Immunology and Allergy Specialists in Australia and New Zealand.
Website: www.allergy.org.au 
Email: This email address is being protected from spambots. You need JavaScript enabled to view it. 
Postal address: PO Box 450 Balgowlah NSW Australia 2093

Disclaimer
This document has been developed and peer reviewed by ASCIA members and is based on expert opinion and the available published literature at the time of review. Information contained in this document is not intended to replace medical advice and any questions regarding a medical diagnosis or treatment should be directed to a medical practitioner.

The development of this document is not funded by any commercial sources and is not influenced by commercial organisations.

Content last updated December 2014

Disclaimer and Privacy

The ASCIA website is intended for use by ASCIA members, other health professionals, the general public and media. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

 

Sponsors and Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites.

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Accreditation

healthdirect
This website is certified by Health On the Net Foundation. Click to verify.This site complies with the HONcode standard for trustworthy health information: verify here.


World Allergy Organization (WAO)

ASCIA is a WAO member society